Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Webinar w $ATE CEO Dan Legault - Mon Nov 21 @ 4:15PM ET
View:
Post by bmreed on Nov 17, 2022 4:00pm

Webinar w $ATE CEO Dan Legault - Mon Nov 21 @ 4:15PM ET

Webinar - Antibe Therapeutics $ATE w/ CEO Dan Legault

Mon, November 21 at 4:15pm ET / 1:15pm PT

Q&A with Radius Research 

Register Here - https://us02web.zoom.us/webinar/register/5216686324941/WN_NEICOjy7TOCAAlEzN3441w

Comment by MrMugsy on Nov 17, 2022 7:00pm
Brings up a good question ... is it Q&A with or without the Q4 IBD update ? If it's without the IBD update, why not wait unitl we get the update, until we get the presentation ... then host a Q&A on all this new stuff too ? Guess we still have Friday and Monday to get an IBD update ... hahaha ! I wouldn't put money on it though !!!!
Comment by StockingUp21 on Nov 17, 2022 7:54pm
Mugoo been pumping this ibd update hundred of times but sadly after 20 years they only have enough money for this without a huge dulution.
Comment by themagicbox on Nov 19, 2022 10:56am
I am looking forward to this. If I had to bet money on it, think Wallace stepped down to focus specifically on IBD. And since this was quiet recent, I wouldnt be surprised if we dont hear an update till mid next year. Just my 2c
Comment by Stutters on Nov 19, 2022 2:27pm
lol... magicbox, you did bet money on it...and we are down to .48 cents from 6 bucks. Your bet has not paid off to say the least.
Comment by Inthepez on Nov 19, 2022 4:36pm
Given all the recent info on nanotechnology in oral pharmaceuticals I am not surprised he stepped down. i suspect the proof concept will expedite the process in general, and that we're on the right track. Less risk overall; at the end of the day, the drug works...perhaps too well lol. I am not sure of medications that uses nanotechnology. I doubt it has many side effects though, since it' ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities